Pharma Industry News
A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.
Stock Movers: Astrazeneca, Schott Pharma, Rheinmetall
Bloomberg journalists discuss today's biggest winners and losers in the stock market. Listen for analysis on the companies making news on Wall Street. Bloomberg journalists discuss today's biggest winners and losers in the stock market. Listen for…
Steve Pagliuca Says AI, Pharma, Sports Are Key Investment Focus
PagsGroup Chief Executive Officer Stephen Pagliuca sees a clutch of growing industries, including artificial intelligence and sports, as a key focus for investment over the long term. AI is entering a 10-to-20-year growth phase as it shifts from…
Nifty reclaims 24,000; midcaps outshine as Dr. Reddy's tanks 5%, pharma diverges
Markets were trading firmly higher by midday on Thursday, July 9, 2026, staging a broad recovery from Wednesday's rout, with the Sensex at 77,054.79, up 551.19 points or 0.72 per cent, and the Nifty 50 at 24,065.15, up 183.10 points or 0.77 per…
Indian Stock Markets Rebound: Sensex, Nifty Up on FII Inflows, Global Cues
Indian stock markets, including the Sensex and Nifty, staged a significant rebound in early trade on Thursday, recovering from a sharp fall in the previous session, bolstered by foreign institutional investor inflows and strategic buying in…
/afaqs/media/media_files/2026/07/09/abbott-2026-07-09-13-32-37.jpg)
Abbott elevates Shefali Singh as head of marketing
Abbott has elevated Shefali Singh to the role of head of marketing. Singh announced the appointment in a LinkedIn post, where she wrote: 'I'm happy to share that I'm starting a new position as Head of Marketing at Abbott!' She has been with Abbott…
Markets Rebound: Nifty, Sensex Closes In Green Amid Oil Jitters
Indian equity benchmarks ended in positive territory on Thursday, with the Nifty closing at 23,962.80, up 80 points or 0.34%, while the Sensex settled at 76,741.82, gaining 238 points or 0.31%. The gains were driven by strength in broader sectoral…
Indian Stock Markets Rebound: Sensex, Nifty Gain Amid Global Cues, FII Inflows
Indian stock markets, including the Sensex and Nifty, staged a moderate rebound today, recovering from a previous session's sharp decline, driven by foreign fund inflows and positive global cues despite lingering geopolitical concerns. The BSE…
Pfizer, Alnylam, BridgeBio gain on Astra/ Ionis setback (PFE:NYSE)
Pfizer (PFE), Alnylam Pharma (ALNY), and BridgeBio Pharma (BBIO), which market drugs for a rare heart condition known as ATTR-CM, are on the rise in the premarket on Thursday after AstraZeneca (AZN) and…
Stock markets rebound in early trade after sharp fall in previous session
Benchmark indices Sensex and Nifty rebounded in early trade on Thursday (July 9, 2026) after a sharp fall in the previous session amid foreign fund inflows and buying in blue-chip stocks. The 30-share BSE Sensex climbed 495.86 points to 76,998.54…
Boom Times For Autoimmune Disease Therapies
In this week's edition of InnovationRx, we look at the boom in autoimmune disease therapies, OpenAI's healthcare push, Vertex's $10 billion purchase of Crinetics, and more. To get it in your inbox, subscribe here. AbbVie's Skyrizi is on track to…
Stock markets bounce back after previous session's drubbing, Sensex climbs 238 points
Market benchmark indices Sensex and Nifty rebounded on Thursday (July 9, 2026) after a heavy correction in the previous session amid foreign fund inflows and a largely positive trend in global markets. However, caution prevailed in the market as…
/afaqs/media/media_files/2026/07/09/vspark-2026-07-09-14-29-42.png)
V Spark Communications rebrands as Fizz PR
V Spark Communications, a leading public relations agency, has announced it is rebranding as Fizz PR, effective immediately. The new name and identity reflect the agency's evolution from a Delhi NCR focused PR firm into a full-spectrum…
Is It Too Late to Buy Eli Lilly?
Eli Lilly (LLY 1.27%) stock has been winning big when it comes to earnings and stock performance in recent years. And this has a lot to do with the company's leadership in a type of drug that's taken the world by storm: GLP-1 drugs for weight loss.
Rush for GLP-1 weight-loss & diabetes drugs plateaus, says industry-tracker
After the race to launch generic semaglutide for weightloss and diabetes, the anti-diabetes market has stabilized, even as innovator drugs hold their own in this category, reveals Pharmatrack's data for June. Innovator companies Novo Nordisk with…
Mission-Driven Media Jobs Hiring Now in 2026
Something worth watching is happening in the mid-2026 job market: organizations with a sharp editorial mission are hiring at the director and senior level, often with remote flexibility baked in. These aren't generic “content” roles…
Receive a Daily briefing on Pharma Industry News
Get Started